LONDON, March 15, 2016 /PRNewswire/ --
Bart will take over management responsibilities from Peter J. Bartlett. In his capacity of CEO, Bart will oversee the management of PBAC's assets and represent the Firm in its various business interests, including PBAC's interest in various Exotix-related entities.
Dr. Bart Turtelboom is currently the Managing Partner and Chief Investment Officer of APQ Partners, LLP, a role he will continue to fulfill. He started his career at the International Monetary Fund where he published extensively on international monetary policy, including ground-breaking research on interest rate liberalization in Africa and the interaction between tax collection and monetary policy in Brazil. Bart joined Deutsche Bank's emerging market group in January 1998 and subsequently worked on benchmark transactions in Argentina, the Philippines and Russia.
Bart joined Morgan Stanley's emerging markets group in 2004, leading to his appointment as global co-head of emerging markets sales and trading in 2006 and head of Morgan Stanley's Emerging Markets Capital Market Group in Europe. Leading a team of one-hundred professionals based in Asia, Latin America and Europe, he built the group into one of Wall Street's pre-eminent proprietary emerging markets trading groups.
On 15 September 2008, Bart and a core team of Morgan Stanley professionals joined GLG Partners to lead its emerging markets practice. In early 2013, Bart co-led GLG's team move to APQ Partners, a London-based emerging markets asset manager where he now serves as Managing Partner and Chief Investment Officer.
During his career, Bart worked on ground-breaking transactions in emerging markets including the first transaction involving Russian Paris-Club debt, the issuance of the largest Eurobonds denominated in Mexican Peso, currency hedging transactions in Turkey and multi-billion dollar lending facilities in the CIS.
Bart obtained his PhD in Economics at Columbia University. He obtained various academic awards including fellowships from The Brookings Institution and the Belgian National Science Foundation.
For further information, please contact Andrew Nicolls on +44(0)7798-626-281